Brown & Brown, Inc.
(BRO) is an insurance intermediary operating in the insurance brokerage and services sector. It has established itself as a leading national provider known for its decentralized operating model and focus on organic growth complemented by strategic acquisitions.
Updated: February 19, 2026, 16:00 EST
Based on a comprehensive analysis, Brown & Brown (BRO) presents a mixed picture for potential investors. Technically, the stock appears oversold after significant underperformance, trading near its 52-week lows, which might attract contrarian buyers. Fundamentally, the company shows strength with solid revenue growth, improved profitability, and a very conservative balance sheet with low debt.
However, these positive operational fundamentals are overshadowed by a very rich valuation. Key metrics like the elevated forward P/E and an exceptionally high EV/EBITDA ratio of 55.9 suggest the stock is priced for near-perfect execution, leaving little margin for error. Furthermore, while its low beta indicates less day-to-day volatility, the massive maximum drawdown reveals a concerning vulnerability to sustained downturns.
Recommendation: HOLD / APPROACH WITH CAUTION
While BRO's underlying business is healthy, its current stock price appears to fully reflect this strength and then some. The combination of a premium valuation and a technically weak chart suggests significant near-term risk. Investors might consider waiting for a more attractive entry point or for clearer signs that earnings growth can sustainably justify the high multiples. For existing shareholders, the strong fundamentals may warrant holding, but new capital may find better risk-reward opportunities elsewhere.
Based on a comprehensive analysis, here is a 12-month outlook for Brown & Brown (BRO):
12-Month Outlook for BRO
Brown & Brown's outlook is balanced between strong operational execution and a demanding valuation. Key positive catalysts for the stock include its solid underlying revenue growth, improved profitability, and a robust balance sheet that provides stability. The primary risk remains its premium valuation, particularly the high EV/EBITDA multiple near 56, which leaves the stock vulnerable to a de-rating if growth disappoints or market sentiment sours. Given the absence of a specific analyst target, the path is highly dependent on earnings performance; the stock is likely to remain range-bound, with significant upside contingent on the company exceeding growth expectations to justify its current price. A price range of $65 - $80 is plausible, reflecting the tug-of-war between its high-quality business and rich multiples.
Recommendation: HOLD
Most Wall Street analysts are optimistic about Brown & Brown, Inc.'s 12-month outlook, with consensus target around $69.42, indicating expected upside potential.
Overall, BRO has investment potential but also faces challenges. Here are key factors to weigh before investing.
Overall Assessment: BRO has experienced substantial underperformance over the past year, characterized by a significant downturn and high maximum drawdown.
Short-term Performance: The stock has declined sharply by over 13% during both the 1-month and 3-month periods, significantly underperforming the broader market by approximately 13.78%. This consistent negative momentum indicates persistent selling pressure relative to market benchmarks.
Current Position: Trading near the lower end of its 52-week range, approximately 6% above its 52-week low and 45% below its high, BRO appears oversold from a technical perspective. Despite its beta below 1 suggesting lower volatility than the market, the stock's current price reflects a deeply depressed valuation.
| Period | BRO Return | S&P 500 |
|---|---|---|
| 1m | -12.2% | +1.0% |
| 3m | -13.3% | +1.9% |
| 6m | -26.7% | +6.5% |
| 1y | -37.8% | +12.1% |
| ytd | -10.6% | +0.2% |
Revenue & Profitability Brown & Brown demonstrated solid revenue growth with Q4 2025 revenue reaching $1.67 billion, up from $1.61 billion in Q3. Profitability metrics improved significantly, with the gross profit ratio expanding to 83.8% from 50.6% in the prior quarter, reflecting enhanced cost control. Net income increased to $264 million (15.8% margin) from $227 million (14.1%), indicating stronger bottom-line performance.
Financial Health The company maintains a conservative capital structure with a debt ratio of just 27% and a long-term debt to capitalization of 36.2%. Interest coverage of 4.29x appears adequate, though the cash flow to debt ratio of 0.055 suggests limited free cash flow relative to debt obligations. The negative cash conversion cycle of -136 days indicates efficient working capital management, as the company collects receivables before paying suppliers.
Operational Efficiency Return on equity stands at 2.1%, while return on assets is modest at 0.88%, indicating room for improvement in capital allocation efficiency. The asset turnover ratio of 0.056 suggests relatively low revenue generation from the asset base. However, the fixed asset turnover of 2.62 shows reasonable utilization of property and equipment, though overall operational efficiency metrics remain subdued.
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
Try Now & Get Tesla Stock RewardBRO's trailing PE ratio of 22.0 and forward PE of approximately 25.1 suggest a moderately high valuation level. The forward PE being higher than the TTM PE indicates expectations of declining earnings, which could signal overvaluation. This is further supported by a PEG ratio of 1.73, which exceeds 1.0, implying the stock's price is not fully justified by its earnings growth prospects and may be overvalued relative to its growth trajectory.
Without specific industry average data for comparison, a precise peer benchmark cannot be established. However, the elevated EV/EBITDA of 55.9 is exceptionally high, typically indicating rich valuation multiples compared to sector norms. Investors should seek industry-specific metrics to contextualize these ratios, as the absence of comparative data limits the conclusiveness of the valuation assessment.
Volatility Risk Analysis: With a beta of 0.786, BRO exhibits lower volatility than the broader market, suggesting reduced directional risk during normal market conditions. However, the substantial one-year maximum drawdown of -46.14% indicates significant downside volatility and vulnerability during market stress periods, highlighting considerable loss potential despite the lower beta reading.
Other Risk Factors: The absence of short interest removes the risk of a short squeeze but may also indicate limited bearish sentiment scrutiny. Given BRO's profile, investors should monitor liquidity metrics and sector-specific risks that could impact performance, as these factors may present material challenges not reflected in the short interest data.
Opinion: Neutral to slightly bearish for short-term investors, but moderately bullish for long-term, value-oriented investors.
Core Reasons: 1. Bearish Technicals vs. Solid Fundamentals: The stock is technically oversold with severe recent underperformance (-13% over 1/3 months), contrasting with fundamentally strong Q4 revenue growth and profitability improvements (net income of $264M). 2. High Valuation Concerns: An unusually high EV/EBITDA of 55.9 and a forward P/E exceeding its trailing P/E suggest the stock may be overvalued despite its price decline, making near-term appreciation challenging. 3. Mixed Analyst & Insider Signals: A consensus "sell" analyst rating and recent insider selling introduce caution, though strategic acquisitions and industry consolidation offer long-term upside potential.
Suitable Investor Types: Primarily suitable for patient, long-term investors who can tolerate near-term volatility and are confident in the company's strategic acquisition model. Less suitable for short-term traders seeking quick gains.
Based on the metrics provided, BRO appears overvalued. Its forward P/E of 25.1 is higher than its trailing P/E, suggesting declining earnings expectations, and its PEG ratio of 1.73 (above 1.0) indicates the stock price is high relative to its growth prospects. While the company shows solid profitability and financial health, the valuation multiples are not supported by the currently modest operational efficiency, such as the low return on equity (2.1%) and asset turnover (0.056). Without industry data for a precise comparison, the high PEG ratio remains a key signal of overvaluation.
Based on the provided information, here are the key risks of holding BRO stock, ordered by importance:
1. Market Volatility Risk: Despite a low beta, the stock has demonstrated extreme downside volatility with a -46.14% maximum drawdown, indicating high susceptibility to severe losses during market downturns. 2. Business Performance Risk: The stock's sharp price decline and position near 52-week lows reflect fundamental concerns, including low operational efficiency metrics like a 0.88% return on assets and a 0.056 asset turnover ratio. 3. Financial Flexibility Risk: The company's cash flow to debt ratio of 0.055 indicates very limited free cash flow relative to its debt obligations, which could constrain financial flexibility, especially if interest rates rise.
Based on a forward-looking projection from the provided 12-month outlook and fundamentals, the forecast for Brown & Brown (BRO) through 2026 is as follows.
My base case target for 2026 is $75 - $85, while a bull case could see shares reach $90 - $100, contingent on the company exceeding growth expectations to justify its premium valuation. Key growth drivers include sustained organic revenue growth, continued margin expansion through cost control, and strategic acquisitions funded by its robust balance sheet. The primary assumptions are that the company maintains its high-quality execution without a significant de-rating of its current EV/EBITDA multiple near 56. This forecast carries high uncertainty, as the stock's path is heavily dependent on quarterly earnings results and broader market sentiment toward highly-valued growth stocks.